FDA Inspection
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCWyeth BioPharma Division of Wyeth Pharmaceuticals LLC – FDA Inspection, Feb 11, 2026
Record Details
This FDA Inspection record concerns Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, with an inspection on February 11, 2026, covering biologics.
- Inspection Date
- February 11, 2026
- Product Type
- Biologics
View Company Profile
ID · 97de66a3-38df-4231-8616-827b2267fbc3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1304580
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
16| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2026 | Not classified | New England District Office | |
| April 8, 2026 | Not classified | New England District Office | |
| October 13, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 3, 2019 | Not classified | New England District Office |
Other documents for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
- FDA Inspection 1331288 - 2026-08-06
- FDA Inspection 1311392 - 2026-04-08
- FDA Inspection 1223617 - 2023-10-13
- FDA Inspection 1218069 - 2023-09-19
- FDA Inspection 1092777 - 2019-05-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.